|
Flash movie failed to load.
|
|||||||||||
 | |||||||||||
|
ValveXchange, Inc.
Notice: ValveXchange, Inc. products have not been approved by the U.S. FDA or any other Regulatory Agencies. This website contains forward looking statements which represent management's best judgment, but are speculative and may not occur as projected or not at all.
|
|
October 5, 2011. Denver - ValveXchange, Inc. has performed successful First In Man (FIM) surgeries demonstrating the practicality and advantages of its novel Vitality™ two-part heart valve system. Read More. July 7, 2011. Atlanta, GA - CryoLife, Inc. (NYSE: CRY), a leading tissue processing and medical device Company focused on cardiac and vascular surgery, announced today a $3.5 million equity investment in ValveXchange® Inc. Read More. February 14, 2011. Denver - ValveXchange Inc. is pleased to announce that Mr. Kevin Morningstar has joined the VXi team as Senior Director, Regulatory Affairs and Quality Assurance. Read More. January 17, 2011. Denver - ValveXchange Inc. is pleased to announce that Mr. Todd Campbell has joined the VXi team as Senior Executive Director of Product Development. Read More. News in 2010 October, 2010. Denver - ValveXchange Inc. is pleased to announce that Blase Carabello, M.D., has joined the VXi Medical Advisory Board. Read More. October, 2010. Denver - ValveXchange Inc. is pleased to announce that Bonnie Vivian has joined the VXi Board of Directors. Read More. September, 2010. Denver - ValveXchange Inc. is pleased to announce that Carlos Ruiz, M.D., Ph.D., has joined the VXi Medical Advisory Board. Read More. August 19, 2010. Denver - ValveXchange Inc. is pleased to announce the receipt of a $1.3 million Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) under the Fast Track program. The Fast Track program is reserved for highly innovative and competitive projects with a short time-line to commercialization. This is VXi's 5th NIH SBIR Grant. June, 2010. Denver - ValveXchange Inc. is pleased to announce that Lars G. Svensson, MD, PhD, has joined the VXi Medical Advisory Board. Read More. April 13, 2010. Minneapolis – Dr. Ivan Vesely, the founder of ValveXchange Inc., presented a review paper entitled “The Three Tenets of Good Valve Design: Where transcatheter Valves Fail”, at the 2010 Design of Medical Devices conference in Minneapolis, Minnesota. Other noted invited speakers were Manny Villafona, the founder of St.Jude Medical, and Dr. Robert Levy, a pioneer in understanding prosthetic valve calcification. Dr. Vesely’s presentation can be viewed here. January, 2010. Denver - ValveXchange Inc. is pleased to announce that it has received a $250,000 grant from the State of Colorado under the Bioscience Discovery Evaluation Grant Program (BDEGP). Read More. News in 2009 November 19, 2009. AURORA – ValveXchange Inc. recently executed a license agreement with the University of Colorado for a process to transform cardiac imaging data into high-quality three-dimensional models used for heart valve product development, clinician training, and pre-procedure planning. Read More. October, 2009. Denver – ValveXchange Inc. is pleased to announce that Dr. Antonio Calafiore has joined the VXi Medical Advisory Board. Dr. Calafiore is recognized internationally for pioneering off-pump coronary artery bypass grafting and the “Calafiore technique” of myocardial preservation. Dr. Calafiore has recently moved from Italy to Riyadh, Saudi Arabia as the director of the Prince Sultan Cardiac Center. Read More. September, 2009. Denver – ValveXchange Inc. is pleased to announce that Michael J. Mack, M.D., has joined the VXi Medical Advisory Board. Dr. Mack is Director of Cardiovascular Research and Cardiovascular Medicine of the Heart Hospital Baylor Plano and Director of Cardiovascular Surgery for the Baylor Healthcare System. He is considered to be the most noted authority on the emerging field of transcatheter valves. Read More. June, 2009. Denver – ValveXchange Inc. announces that Walter Randolph “Randy” Chitwood, Jr., M.D., FACS, FRCS has joined the VXi Medical Advisory Board. Dr. Chitwood was the principal investigator of the FDA robotic mitral valve trials that led to approval for this use in the United States. Today, he is the world’s leader in robotic mitral valve surgery. Read More. May 15, 2009. Denver - ValveXchange Inc. is pleased to announce that it has signed an option agreement with Dr. Gerard Guiraudon to license his Universal Cardiac Introducer technology. Unlike rigid trocars, the Guiraudon Universal Cardiac Introducer (GUCI) is a flexible, collapsible system that facilitates intracardiac surgery and off-pump exchange of the VXi valve. Read More. March 18, 2009. San Francisco, CA – Frost and Sullivan held their annual “Excellence in Medical Technologies & Life Sciences Awards” banquet on this date, honoring companies in the bioscience and medical device fields. ValveXchange Chairman and CEO, Larry Blankenship, was there to accept the award. Read More. March, 2009. Denver – ValveXchange Inc. announced that Dr. Tirone E. David has joined the VXi Medical Advisory Board. Dr. David is recognized world-wide for his pioneering work in valve sparing surgery, his remarkable surgical skills and his commitment to teaching. Read More. March 30, 2009. Denver - ValveXchange licensed its exchangeable valve technology patents from the Cleveland Clinic. The Clinic and ValveXchange have now entered into an arrangement whereby the Cleveland Clinic will in the future receive an equity position in ValveXchange, Inc. Read More. February, 2009. Denver - ValveXchange Inc. announced that it is the recipient of the 2009 North American Frost & Sullivan Technology Innovation of the Year Award. According to Frost & Sullivan Research Analyst S.R. Priya, "The ValveXchange Heart Valve System represents a safe and less invasive alternative to conventional therapies.... Overall, the ValveXchange system provides the innate hemodynamic and non-thrombogenic benefits of tissue valves to patients of all ages, thus obviating the need for expensive and potentially problematic anti-coagulation therapies and major lifestyle modifications.” concludes Priya. February, 2009. Denver - ValveXchange Inc. announced that of Dr. Joseph Sabik, Chair of Cardiothoracic Surgery, The Cleveland Clinic Foundation, will serve as the Chair of the VXi Medical Advisory Board. Read More. January 30, 2009. Denver - ValveXchange Inc. announced that it has begun animal testing of its proprietary exchangeable valve technology, working with the College of Veterinary Medicine at the Colorado State University, Fort Collins, CO, and with Experimental Surgical Services, University of Minnesota, Minneapolis, MN. Both Institutions are well-recognized for their expertise in animal surgery. Read More. News in 2008 November, 2008. Denver – Dr. Floyd Loop, former CEO of The Cleveland Clinic Foundation, has joined the Board of Directors of ValveXchange Inc., and will also chair the Medical Advisory Board. Read More. October 23, 2008. Denver - Aurora-based medical device has recently been featured in an article posted by the RockyRadar, a local medical device industry newsletter. The review of the ValveXchange approach is one in a series of short stories about start-up companies in the Denver-Boulder area, primarily in the areas of Life Sciences, Information Technologies and Clean Energy. Read More. October 13, 2008. DENVER—Aurora-based medical device company ValveXchange Inc. announced today that it has been awarded a European patent (EP1,671,608) entitled Cardiovascular Valve Assembly, authored by Dr. Ivan Vesely, the company’s Founder and Chief Scientific Officer. Read More. July 29, 2008. DENVER—Aurora-based medical device company ValveXchange Inc. announced today that they have received a $1.6 million grant from the National Institutes of Health (NIH) for funding under the SBIR Program related to research and development of its proprietary two-piece heart valve technology. Read More. January 1, 2008. ValveXchange Inc. is a featured company in Start-Up magazine. Read More. News in 2007 December 7, 2007. Wins the Third Annual Faegre & Benson Venture Showcase Award. Read More. Archive Newsletters (pdf) 2010 May-June 2010 2009 2008
|
|
|||||||
| |||||||||||
| |||||||||||
|
©2008-2011 ValveXchange, Inc. - All Rights Reserved | Legal Notices | Site Map | Web Development: Oliva Ventures
|
|||||||||||
